Sun Pharma
Search results
Natco Pharma is a leading pharmaceutical company specializing in oncology, generic medications, and innovative solutions for crop health. Discover their high-quality healthcare products.
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations active pharmaceutical ingredients and Agro chemical products. [5] ... NATCO is a science driven company and focuses on limited competition molecules in the US. [10] [11] History. NATCO Pharma was founded in the year 1981 by V C Nannapaneni;
3 days ago · Natco Pharma share price was Rs 1,376.55 as on 14 Nov, 2024, 03:59 PM IST. Natco Pharma share price was up by 0.71% based on previous share price of Rs 1,376.55. Natco Pharma share price trend: Last 3 Months: Natco Pharma share price moved down by 5.64%; Last 12 Months: Natco Pharma share price moved up 81.45%
5 days ago · Natco Pharma on Tuesday said its consolidated net profit jumped 83 per cent on-year to Rs 676 crore in the September 2024 quarter, aided by robust sales.The drug maker reported a net profit of Rs 369 crore in the July-September period of last fiscal. Revenue from operations rose to Rs 1,371 crore as compared with Rs 1,031 crore in the year-ago period, the company said in a regulatory filing.
Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (“FDF”) and active pharmaceutical ingredients (“APIs”). Our focus is primarily on niche therapeutic areas and complex products.
4 days ago · Natco Pharma Limited Stock Price Today, Live NSE Share Price: Get the latest Natco Pharma Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
Jan 5, 2024 · Natco Pharma Limited (NSE: NATCOPHARM; BSE: 524816) and Alvogen, who have partnered on the first Abbreviated New Drug Application (ANDA) containing a paragraph IV certification filed with the U.S. Food and Drug Administration (FDA) for generic versions of Oseltamivir phosphate oral capsules, 30 mg, 45 mg and 75 mg, announced today that they have settled the patent infringement suit filed by Gilead Sciences, Inc., Hoffmann-La Roche Inc., F. Hoffmann-La Roche Ltd. and Genentech, Inc. against ...
NATCO Pharma | 64,192 followers on LinkedIn. Making specialty medicines accessible to all | NATCO Pharma is a vertically integrated company dedicated to the development, manufacture, and...
Get the latest Natco Pharma Ltd. (NATCOPHARM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
4 days ago · Currently, Natco Pharma boasts a market capitalization of ₹ 24,911.5 crore, with a 52-week high of ₹ 1,639 and a low of ₹ 752.45. As of November 13, 2024, analysts' opinions on Natco Pharma ...
